An advisory panel of the Federal Drug Administration (FDA) recently recommended approval of a medication manufactured by Amgen as a feasible alternative product to Humira, a brand created by AbbVie. Read More »
Xiidra has been approved by the U.S. Food and Drug Administration (FDA) to treat the signs and symptoms of dry eye disease. Read More »
Stent releases drug to reduce scar tissue in coronary arteries after angioplasty. Read More »
Twenty-year FDA veteran tapped to lead OCE through initial phase. Read More »
Calls on Congress to ban direct-to-consumer advertising; approves policies to help prevent controlled substance abuse. Read More »
American consumers will be able to enjoy the benefits of drug competition that results in more choice and lower prices for life-saving drugs via the newly proposed Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, U.S. Sen. Chuck Grassley (R-Iowa) said. Read More »
A bipartisan bill introduced this week in the Senate would allow generic drug companies to sue the brand-name marketplace giants for samples and safety protocols. Read More »
The American Society of Health-System Pharmacists (ASHP) announced this week that it has awarded Geisinger Health System with its Board of Directors Award of Excellence during the ASHP Summer Meetings. Read More »
The American Society of Health-System Pharmacists (ASHP) announced this week that it has approved a measure that urges Congress to ban advertisements for prescription medication and related devices. Read More »
The American Society of Health-System Pharmacists (ASHP) announced Wednesday that Lisa Gersema was selected as the organization’s president during its Summer Meetings and Exhibition in Baltimore. Read More »
The U.S. Food and Drug Administration (FDA) announced this week that it has taken legal action against 4,402 websites that had been selling illicit prescription drugs and unapproved prescription drugs. Read More »
Liver disease therapy Ocaliva granted accelerated approval by FDA. Read More »
Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »
The American Society of Health-System Pharmacists (ASHP) had representatives at a White House meeting regarding opioid abuse this week. Read More »
The U.S. Food and Drug Administration (FDA) announced that it has approved a buprenorphine implant for the treatment of opioid dependence this week. Read More »
A new law in Indiana gives pharmacists the freedom of judgment to determine whether to dispense decongestants in an effort to interrupt the supply chain that produces methamphetamines Read More »
Maine Gov. Paul R. LePage recently signed into law a new state law that limits the doses, duration, and overall prescription of opioid therapies. Read More »
Targeted treatment with Tecentriq approved; it is the first PD-L1 inhibitor approved by FDA for urothelial carcinoma. Read More »
New certificate program added to ASHP online continuing education program for pharmacists and pharmacy technicians. Read More »
Alex Brill, CEO of Washington, D.C.-based economic policy consulting firm Matrix Global Advisors, recently published a strategic proposal suggesting how payors can support biosimilar utilization. Read More »
Alerts Sign-up
